Rare diseases
Investigational molecules
Locations
Back to Denmark35 clinical trials in Gistrup, Denmark. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)DenmarkOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
DenmarkStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
DenmarkDenmarkStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
DenmarkRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
DenmarkA Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety
DenmarkA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
DenmarkA study evaluating the effect of methylprednisolone compared to sodium chloride in patients with a heart attack
DenmarkA study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.
DenmarkA study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis
DenmarkStudy of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on heart failure prevention through combination therapy studies. Clinical trials are evaluating the effectiveness of baxdrostat in combination with dapagliflozin for reducing cardiovascular mortality risk.
These studies aim to advance treatment options for patients at elevated risk of developing heart failure.
Groundbreaking research investigating chronic kidney disease management in patients with type 1 diabetes. Studies are examining the efficacy of finerenone as an addition to standard care treatment protocols.
This research focuses on developing enhanced therapeutic approaches for complex diabetic kidney complications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
